Recently, overexpression of COX-2 has been indicated in specific types of canine mammary carcinomas, including tubulopapillary, anaplastic, squamous cell carcinoma as well as carcinosarcomas [25, 26]. This evidence concerns the gene PTGS2 and breast carcinoma.